Home       Privacy       Archive       Realtime Report



Stock Trading History of Crooke Stanley T

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Crooke Stanley T since year 2005. The trader's CIK number is 897667. At the time of this reporting, Crooke Stanley T is the Chairman, President, CEO of Isis Pharmaceuticals Inc (stock ticker symbol ISIS).

Stock purchases, sales, and option exercises reported by Crooke Stanley T since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2007-12-27 ISIS Isis Pharmaceuticals Inc Sale 6,000 16.32 97,926
2007-12-28 ISIS Isis Pharmaceuticals Inc Sale 20,000 16.22 324,430
2007-12-26 ISIS Isis Pharmaceuticals Inc Option Exercise 24,000 12.31 295,500
2007-12-27 ISIS Isis Pharmaceuticals Inc Option Exercise 8,100 12.31 99,731
2007-12-26 ISIS Isis Pharmaceuticals Inc Sale 24,000 16.53 396,619
2007-12-28 ISIS Isis Pharmaceuticals Inc Option Exercise 20,000 12.31 246,250
2007-12-11 ISIS Isis Pharmaceuticals Inc Option Exercise 20,000 12.31 246,250
2007-12-11 ISIS Isis Pharmaceuticals Inc Sale 20,000 17.37 347,480
2007-11-28 ISIS Isis Pharmaceuticals Inc Option Exercise 30,000 5.15 154,500
2007-11-30 ISIS Isis Pharmaceuticals Inc Option Exercise 29,851 5.15 153,732
2007-11-28 ISIS Isis Pharmaceuticals Inc Sale 30,000 18.01 540,330
2007-11-30 ISIS Isis Pharmaceuticals Inc Sale 29,851 18.03 538,153
2006-11-09 ISIS Isis Pharmaceuticals Inc Sale 20,000 10.13 202,600
2006-11-10 ISIS Isis Pharmaceuticals Inc Sale 10,000 10.40 104,050
2006-11-13 ISIS Isis Pharmaceuticals Inc Sale 20,000 13.36 267,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Crooke Stanley T (Chairman, President, CEO of Isis Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.